Nanobiotix is a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer.
The company is listed on the regulated market of Euronext in Paris (access to Nanobiotix share price on our Euronext profile).
The company Headquarter is based in Paris, France, and has an affiliate in Cambridge (MA) United States.
|Issued Shares||22 360 039|
NANOBIOTIX SHAREHOLDING STRUCTURE (DEC 2018)
Management & Employees6%
NANOBIOTIX ANALYST COVERAGE
|STIFEL (UK)||Christian Glennie|
|JEFFERIES (UK)||Peter Welford|
|GILBERT DUPONT (FR)||Jamila El Bougrini|
|KEMPEN (NL)||Ingrid Gafanhao|
|KEPLER CHEUVREUX (FR)||Arsène Guekam|
|H.C. WAINWRIGHT & Co. (US)||Ramakanth Swayampakula|
|PORTZAMPARC (FR)||Christophe Dombu|
|DEGROOF PETERCAM (BE)||Benoit Louage|